Cryo-Cell International(CCEL)
Search documents
Cryo-Cell International(CCEL) - 2022 Q3 - Quarterly Report
2022-10-18 00:31
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended August 31, 2022 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from to Commission File Number 001-40767 CRYO-CELL INTERNATIONAL, INC. (Exact name of Registrant as Specified in its Charter) DELAWARE 22-3023093 (State or other Jurisdictio ...
Cryo-Cell International(CCEL) - 2022 Q2 - Quarterly Report
2022-07-11 21:01
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended May 31, 2022 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from to Commission File Number 001-40767 CRYO-CELL INTERNATIONAL, INC. (Exact name of Registrant as Specified in its Charter) DELAWARE 22-3023093 (State or other Jurisdiction o ...
Cryo-Cell International(CCEL) - 2022 Q1 - Quarterly Report
2022-04-13 20:31
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended February 28, 2022 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from to Commission File Number 001-40767 CRYO-CELL INTERNATIONAL, INC. (Exact name of Registrant as Specified in its Charter) DELAWARE 22-3023093 (State or other Jurisdict ...
Cryo-Cell International(CCEL) - 2021 Q4 - Annual Report
2022-02-22 22:01
U.S. Securities and Exchange Commission Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended November 30, 2021 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission File Number 001-40767 CRYO-CELL INTERNATIONAL, INC. | --- | --- | --- | --- | --- | --- | |------------------------------------------------------------------------------|------------ ...
Cryo-Cell International(CCEL) - 2021 Q3 - Quarterly Report
2021-10-15 21:01
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value CCEL The Nasdaq Stock Market LLC Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☑ Emerging growth company ☐ FORM 10-Q (Mark One) ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended August 31, 2021 ☐ Transition report purs ...
Cryo-Cell International(CCEL) - 2021 Q2 - Quarterly Report
2021-07-15 21:21
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value CCEL OTCQB Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☑ Emerging growth company ☐ FORM 10-Q (Mark One) ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended May 31, 2021 ☐ Transition report pursuant to Section 13 or 15( ...
Cryo-Cell International(CCEL) - 2021 Q1 - Quarterly Report
2021-04-14 21:21
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended February 28, 2021 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from to Commission File Number 0-23386 | --- | --- | |--------------------------------------------------------------------------------------------------------------------- ...
Cryo-Cell International(CCEL) - 2020 Q4 - Annual Report
2021-03-01 22:21
Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value CCEL OTCQB U.S. Securities and Exchange Commission Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended November 30, 2020 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission File Number 000-23386 CRYO-CELL INTERNATIONAL, INC. (Exact Na ...
Cryo-Cell International(CCEL) - 2020 Q3 - Quarterly Report
2020-10-15 21:00
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value CCEL OTCQB Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☑ Emerging growth company ☐ FORM 10-Q (Mark One) ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended August 31, 2020 ☐ Transition report pursuant to Section 13 or ...
Cryo-Cell International(CCEL) - 2020 Q2 - Quarterly Report
2020-07-10 21:15
Table of Contents Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, $0.01 par value CCEL OTCQB Emerging growth company ☐ U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended May 31, 2020 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from to Commi ...